MedPath

Orchidpharma Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

FDA:8

Drug Approvals

Naratriptan

Approval Date
Jan 13, 2022
FDA

ESZOPICLONE

Approval Date
Jan 13, 2022
FDA

Sumatriptan

Approval Date
Jan 13, 2022
FDA

Modafinil

Approval Date
Jan 13, 2022
FDA

Granisetron Hydrochloride

Approval Date
Jan 13, 2022
FDA

terbinafine hydrochloride

Approval Date
Jan 13, 2022
FDA

Aripiprazole

Approval Date
Feb 26, 2021
FDA

Cephalexin

Approval Date
Aug 30, 2012
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.